Relevance of ER to the development of endometrial hyperplasia and adenocarcinoma

Breast Cancer

Volumn 6, Issue 4, 1999, Pages 312-319

  Kato, Kiyoko ^a   Horiuchi, Shinji ^a   Terao, Yasuhisa ^a   Ueoka, Yousuke ^a   Nishida, Jun Ichi ^a   Mori, Daisuke ^a   Yoshikawa, Yasuji ^a   Wake, Norio ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Endometrial carcinoma; ER; PR; Ras; Transformation

Indexed keywords

EID: 2442508751     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/BF02966446     Document Type: Review

References (14)

1. Vojek AB, Hollenberg SM, Cooper JA: Mammalian ras interacts directly with serine/threonine kinase Raf. Cell 74:205-214, 1993. (Pubitemid 23219891)
2. Warne R Viciana R Downward J: Direct interaction of ras and the aminoterminal region of Raf-1 in vitro. Nature 364:352-355, 1993. (Pubitemid 23265279)
3. Zhang XF, Settleman J, Kyriakis JM, et al: Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1. Nature 364:308-313, 1993. (Pubitemid 23265270)
4. Coezy E, Borgna JL, Rochefort H: Tamoxifen and metabolites in MCF-7 cells; Correlation between binding to estrogen receptor and inhibition of cell growth. Cancer Res 42:317-323, 1982. (Pubitemid 12207285)
5. Petrangeli E, Lubrano C, Ortolani F, et al: Estrogen receptors; New perspectives in breast cancer management. J Steroid Biochem Mol Biol 49:327-331, 1994. (Pubitemid 24240618)
6. Kato S, Endoh H, Masuhiro Y, et al: Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270:1491-1494, 1995.
7. 12Val] K-Ras mediated NIH3T3 cell transformation. Oncogene 15:3037-3046, 1997. (Pubitemid 28043483)
8. Meyer M-E, Gronemeyer H, Turcotte B, et al: Steroid hormone receptors compete for factors that mediate their enhancer function. Cell 57:433-442, 1989. (Pubitemid 19126276)
9. Rose PG: Endometrial carcinoma. N Engl J Med 335:640-649, 1996. (Pubitemid 26277956)
10. Enomoto T, Inoue M, Perantoni AO, et al: K-ras activation in neoplasms of the human female reproductive tract. Cancer Res 50:6139-6145, 1990. (Pubitemid 20323664)
11. Enomoto T, Inoue M, Perantoni AO, et al: K-ras activation in premalignant and malignant epithelial lesion of the human uterus. Cancer Res 51:5308-5314, 1991.
12. Sasaki H, Nishii H, Takahashi H, et al: Mutation of the Ki-ras protooncogene in human endometrial hyperplasia and carcinoma. Cancer Res 53:1906-1910, 1993. (Pubitemid 23127123)
13. Caduff RF, Johnston CM, Frank TS: Mutation of the Ki-ras oncogene in carcinoma of the endometrium. Am J Pathol 146:182-188, 1995.
14. Nisolle M, Menten Y, C-Roux F, et al: Immunohistochemical analysis of estrogen and progesterone receptors in endometrium and peritoneal endometriosis; A new quantitative method. Fertil Steril 62:751-759, 1994. (Pubitemid 24307569)